InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: None

Thursday, 02/15/2018 11:17:29 AM

Thursday, February 15, 2018 11:17:29 AM

Post# of 1445
Data from BioTime's OpRegen® and Vision Restoration Programs to Be Presented at ARVO 2018

https://tinyurl.com/ya6pwc2w

MAYDAY! MAYDAY!

The press release does not give away much concerning presentations at the eye and and vision research meet on April 29 and May 1 but this is a bit of a grabber I thought:

Vision Restoration Paper Presentation

Title: Transplantation of laboratory-grown human retinal tissue in the subretinal space of the CAT EYE
[emphasis added]

Sounds to me like that could generate some headlines in the mainstream media.

But then it's my dubious opinion that OpRegen is a likely spectacular flying not just below the radar but tunneling underground.

Restoring Miss Kitty's eyesight [my unrestrained imagination for now] could be more than a one day sensation.

Please don't let my stargazing cloud your vision. The only tidbit I have to offer was mention at the annual meeting last year of curing of blind mice of their lack of vision. It was brought up by a shareholder and downplayed by Mike West.

Best, Terry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News